H.R. 1946 117th Congress
Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021
- Health
- Sponsor: Rep. Sewell, Terri A. [D-AL-7]
- Congress.gov ↗
Latest action, Mar 17, 2021: Referred to the Subcommittee on Health.
How the Senate voted
The Senate hasn't taken a roll call on this bill in the Congresses covered.
257 cosponsors
Sponsored by Rep. Sewell, Terri A. [D-AL-7] (Democrat). Cosponsors by party, House members included:
- Democrats
- Republicans
- Independents
Cosponsors
148 D · 109 R
- Democrat
- Republican
- Independent
Referred to: House: Energy and Commerce Committee; House: Ways and Means Committee
Who lobbied on it
Clients whose quarterly lobbying reports named it, each quarter.
The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.
8 reports
8 reports
8 reports
EXACT SCIENCES CORPORATION
ARENTFOX SCHIFF LLP
8 reports
GRAIL, INC
ALEXANDER J. BECKLES, L.L.C.
8 reports
8 reports
GRAIL, INC.
AVENUE SOLUTIONS
8 reports
GRAIL, INC.
THE MCMANUS GROUP
8 reports
GRAIL, INC.
FORBES-TATE
8 reports
8 reports
OVARIAN CANCER RESEARCH FUND ALLIANCE
8 reports
EXACT SCIENCES CORPORATION
ALPINE GROUP PARTNERS, LLC.
7 reports
GRAIL LLC
MILLER STRATEGIES, LLC
7 reports
All 25 of 33 clients
| Client | Lobbying firm | Reports | Reports totaling | From | To | Senate |
|---|---|---|---|---|---|---|
| AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC | 8 | $9.3M | Q1 2021 | Q3 2022 | yes | |
| AMERICAN LUNG ASSOCIATION | 8 | $470K | Q1 2021 | Q3 2022 | yes | |
| ASSOCIATION FOR CLINICAL ONCOLOGY | 8 | $1.0M | Q1 2021 | Q3 2022 | yes | |
| EXACT SCIENCES | 8 | $3.0M | Q1 2021 | Q3 2022 | yes | |
| EXACT SCIENCES CORPORATION | ARENTFOX SCHIFF LLP | 8 | $0 | Q1 2021 | Q3 2022 | yes |
| GRAIL, INC | ALEXANDER J. BECKLES, L.L.C. | 8 | $0 | Q1 2021 | Q3 2022 | — |
| GRAIL, INC. | 8 | $5.0M | Q1 2021 | Q3 2022 | yes | |
| GRAIL, INC. | AVENUE SOLUTIONS | 8 | $0 | Q1 2021 | Q3 2022 | yes |
| GRAIL, INC. | THE MCMANUS GROUP | 8 | $0 | Q1 2021 | Q3 2022 | yes |
| GRAIL, INC. | FORBES-TATE | 8 | $0 | Q1 2021 | Q3 2022 | yes |
| GUARDANT HEALTH | 8 | $1.7M | Q1 2021 | Q3 2022 | yes | |
| OVARIAN CANCER RESEARCH FUND ALLIANCE | 8 | $0 | Q1 2021 | Q3 2022 | yes | |
| THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN | 8 | $520K | Q1 2021 | Q3 2022 | yes | |
| EXACT SCIENCES CORPORATION | ALPINE GROUP PARTNERS, LLC. | 7 | $0 | Q4 2021 | Q3 2022 | yes |
| GRAIL LLC | MILLER STRATEGIES, LLC | 7 | $0 | Q4 2021 | Q3 2022 | yes |
| SUSAN G. KOMEN | ARTEMIS POLICY GROUP LLC | 7 | $292K | Q4 2021 | Q3 2022 | yes |
| ASTRAZENECA PHARMACEUTICALS LP | 6 | $7.2M | Q4 2021 | Q3 2022 | yes | |
| GRAIL, INC. | BALLARD SPAHR LLP | 5 | $0 | Q4 2021 | Q3 2022 | yes |
| GRAIL | AVOQ, LLC | 4 | $0 | Q1 2022 | Q3 2022 | yes |
| INTERNATIONAL ASSOCIATION OF FIRE FIGHTERS | 4 | $455K | Q1 2022 | Q3 2022 | yes | |
| GRAIL, INC. | TODD STRATEGY GROUP | 3 | $0 | Q4 2021 | Q4 2022 | yes |
| ADAPTIVE BIOTECHNOLOGIES | ARNOLD & PORTER KAYE SCHOLER LLP | 2 | $150K | Q4 2022 | Q3 2022 | yes |
| ASSOCIATION FOR MOLECULAR PATHOLOGY | IPOLICY SOLUTIONS | 2 | $84K | Q1 2021 | Q2 2021 | yes |
| CHRONIC CARE POLICY ALLIANCE | 2 | $250K | Q4 2022 | Q3 2022 | yes | |
| EXACT SCIENCES | THE DUBERSTEIN GROUP INC. | 2 | $0 | Q4 2022 | Q3 2022 | yes |